Open AccessTherapeutic effect of early intensive antihypertensive treatment on rebleeding and perihematomal edema in acute intracerebral hemorrhage
Author(s) -
Zang Yanjing,
Zhang Chenhao,
Song Qin,
Zhang Jing,
Li Hongxuan,
Zhang Chunliang,
Feng Shanshan,
Gu Fang
Publication year - 2019
Publication title -
the journal of clinical hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.909
H-Index - 67
eISSN - 1751-7176
pISSN - 1524-6175
DOI - 10.1111/jch.13629
Subject(s) - medicine , intracerebral hemorrhage , anesthesia , edema , hematoma , brain edema , blood pressure , gastroenterology , surgery , subarachnoid hemorrhage
To observe the effect of early intensive blood pressure (BP)–lowering treatment on rebleeding and perihematomal edema (PE) in patients with acute intracerebral hemorrhage (ICH). A total of 121 patients with ICH were randomly assigned to an early intensive antihypertensive treatment group (IG) (n = 62) or control group (CG) (n = 59). For both groups, 25 mg of urapidil injection was slowly administered intravenously in 6 hours of the onset. For the IG, 100 mg of urapidil and 30 mL of 0.9% sodium chloride were then slowly administered. Repeat computed tomography imaging was performed at 24 hours, 72 hours, day 7, and day 14 to detect any rebleeding via changes in hematoma volume and the changes in PE. Finally, NIHSS scores and Barthel Index (BI) were calculated at 24 hours, 72 hours, day 7, day 14, day 30, and day 90. The average hematoma volume in IG patients was significantly smaller than that of CG patients after 24 hours ( P < .05). The volume of PE in the CG increased more than in the IG within 24 hours of onset, but was not statistically significant ( P > .05); however, this trend was statistically significant after 72 hours ( P < .05). On day 30 and day 90, the average NIHSS score of IG patients was lower than that of CG patients, and the BI was higher ( P < .05) than that of CG patients. There was no significant difference in mortality between the two groups. Early intensive antihypertensive treatment in ICH patients reduces rebleeding and PE, improving short‐term quality of life.